Artrya (ASX: AYA)
A$0.69
(0.0%)
A$0.00
Price as of June 17, 2025, 10:55 p.m. ET
Artrya Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Artrya Company Info
Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). It uses artificial intelligence (AI) to improve the detection and management of coronary artery disease. The company was founded by John Windsor Barrington and John Konstantopoulos on January 24, 2018 and is headquartered in West Perth, Australia.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.